Mehdi O.
- Country
- France
- Department
- Réanimation et Surveillance Continue Médico-Chirurgical
Research Overview
- Evaluation of Dexamethasone Phosphate for Reducing Respiratory Distress Post-Extubation in Pediatric Intensive Care: A Randomized, Double-Blind, Multicenter Study
- Phase I/II Open‑Label Study Assessing Safety and Efficacy of LV‑FOXP3‑T4 Induced CD4⁺ Treg Cell Therapy ± Low‑Dose Aldesleukin in Patients with IPEX Syndrome
- Dose Adjustment of Enoxaparin Sodium via Bayesian Pharmacological Approach in Pediatric Renal Transplant Recipients with Allograft Vascular Thrombosis
Data & Insights
Has run more than one trial at 4 of 13 partner sites.
Specializations
Rare Disease Management
Specializes in developing therapeutic approaches for Familial Hemophagocytic Lymphohistiocytosis (FHL), with particular focus on genetic therapy solutions for patients with UNC13D gene mutations.
- Gene Therapy Development
- Hematopoietic Stem Cell Treatment
- Autologous Cell Therapy
Investigates novel therapeutic strategies involving modified cellular treatments for rare genetic disorders.
Transplant Medicine
Focuses on preventing complications in pediatric renal transplantation, particularly addressing allograft vascular thrombosis through anticoagulation optimization.
- Pediatric Renal Transplantation
- Anticoagulation Management
- Clinical Pharmacology
Employs innovative pharmacological approaches to improve transplant outcomes in pediatric patients.
Pediatric Medicine
Specializes in developing personalized treatment protocols for young patients requiring complex medical interventions, with emphasis on transplant medicine and genetic disorders.
- Personalized Medicine
- Treatment Optimization
- Complex Medical Conditions
Advances therapeutic strategies specifically tailored to pediatric patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.